Publication | Open Access

Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell types

Somatic VariantExtracellular DomainMedicineCell BiologySomatostatin ReceptorCancer BiologyRadiation OncologyCancer ResearchTumor MicroenvironmentTumor Biology